Published in Exp Neurol on August 01, 2014
Glia as drivers of abnormal neuronal activity. Nat Neurosci (2015) 0.99
Imaging innate immune responses at tumour initiation: new insights from fish and flies. Nat Rev Cancer (2015) 0.85
Extracellular matrix composition determines astrocyte responses to mechanical and inflammatory stimuli. Neurosci Lett (2015) 0.80
The organotypic longitudinal spinal cord slice culture for stem cell study. Stem Cells Int (2015) 0.78
Hyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative Diseases. Int J Cell Biol (2015) 0.78
IL-17 induces reactive astrocytes and up-regulation of vascular endothelial growth factor (VEGF) through JAK/STAT signaling. Sci Rep (2017) 0.78
Lipopolysaccharide Effect on Vascular Endothelial Factor and Matrix Metalloproteinases in Leukemic Cell Lines In vitro. Iran J Cancer Prev (2015) 0.75
Covalent growth factor tethering to direct neural stem cell differentiation and self-organization. Acta Biomater (2017) 0.75
Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation. J Neuroinflammation (2017) 0.75
Hyaluronic Acid in Vascular and Immune Homeostasis during Normal Pregnancy and Preeclampsia. Acta Naturae (2016) 0.75
miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair. J Neurosci (2016) 0.75
RegenBase: a knowledge base of spinal cord injury biology for translational research. Database (Oxford) (2016) 0.75
Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling. Nat Cell Biol (2016) 0.75
TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults. Sci Rep (2017) 0.75
CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 11.01
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 8.22
Nonresolving inflammation. Cell (2010) 7.74
The molecular elasticity of the extracellular matrix protein tenascin. Nature (1998) 6.98
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol (2004) 6.83
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature (2009) 6.67
Hyaluronan. FASEB J (1992) 6.67
Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci (2004) 5.70
Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci (2004) 5.59
Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem (1998) 4.86
The specific interaction of hyaluronic acid with cartillage proteoglycans. Biochim Biophys Acta (1972) 4.44
Functional regeneration of respiratory pathways after spinal cord injury. Nature (2011) 4.07
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest (2005) 3.99
Signaling properties of hyaluronan receptors. J Biol Chem (2001) 3.95
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87
Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol (2007) 3.62
Proteoglycans: many forms and many functions. FASEB J (1992) 3.57
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol (1997) 3.06
The cellular inflammatory response in human spinal cords after injury. Brain (2006) 3.01
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest (1996) 2.86
Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol (2010) 2.85
Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci (2006) 2.81
Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol (1999) 2.78
Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest (2001) 2.78
Hyaluronan synthases. J Biol Chem (1997) 2.76
Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci (1991) 2.73
The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn (2000) 2.65
Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J (1993) 2.64
Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci (2005) 2.61
Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem (2008) 2.53
Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med (2005) 2.51
The role of heparan sulphate in inflammation. Nat Rev Immunol (2006) 2.51
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol (1992) 2.45
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J (2006) 2.41
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31
The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol (2003) 2.28
Overview of the matrisome--an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol (2012) 2.26
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann Neurol (2012) 2.25
The interaction of versican with its binding partners. Cell Res (2005) 2.22
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci (2002) 2.21
Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol (1997) 2.16
Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res (2003) 2.04
NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci (2002) 2.03
Hyaluronan and homeostasis: a balancing act. J Biol Chem (2001) 2.03
Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem (2007) 1.92
The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci (1999) 1.87
Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest (2007) 1.84
The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci (2010) 1.84
Syndecans in inflammation. FASEB J (2003) 1.84
Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol (2006) 1.84
Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci (2008) 1.83
A six-armed oligomer isolated from cell surface fibronectin preparations. Nature (1984) 1.82
Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci (2009) 1.81
Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res (2009) 1.80
Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci (2004) 1.80
Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci (2013) 1.79
Setting the stage for functional repair of spinal cord injuries: a cast of thousands. Spinal Cord (2005) 1.73
The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal (2009) 1.72
Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci (1999) 1.68
Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol (2007) 1.67
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol (2004) 1.62
Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol (2001) 1.60
The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J Biol Chem (1995) 1.59
A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol (1996) 1.58
Molecular identification of a putative human hyaluronan synthase. J Biol Chem (1996) 1.54
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J Neurosci (1994) 1.53
Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol (2004) 1.53
Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci (2009) 1.46
Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem (1998) 1.46
Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res (2008) 1.42
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology (2006) 1.39
Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav Immun (2009) 1.37
The perineuronal net and the control of CNS plasticity. Cell Tissue Res (2012) 1.36
MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol (2007) 1.36
Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J Pathol (2012) 1.36
Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci (1993) 1.35
Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci (2009) 1.35
Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem (2003) 1.34
An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci (2003) 1.34
Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci (1997) 1.33
CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol (2007) 1.32
Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci (2004) 1.32
Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J (2003) 1.32
Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res (1989) 1.32
Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials (2005) 1.32
The integrin receptor alpha 8 beta 1 mediates interactions of embryonic chick motor and sensory neurons with tenascin-C. Neuron (1995) 1.31
The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci U S A (1997) 1.29
Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci Transl Med (2010) 1.28
Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med (2008) 1.28
Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor Neurol Neurosci (2008) 1.26
Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc Natl Acad Sci U S A (1998) 1.26
Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol (2010) 1.25
J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J Cell Biol (1989) 1.24
Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci (2008) 1.23